Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Parc: a cytoplasmic anchor for p53.

Nikolaev AY, Li M, Puskas N, Qin J, Gu W.

Cell. 2003 Jan 10;112(1):29-40.

2.

Parc-ing p53 in the cytoplasm.

Kastan MB, Zambetti GP.

Cell. 2003 Jan 10;112(1):1-2.

3.
4.
5.

Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S.

Cell. 2003 Mar 21;112(6):779-91.

6.

Oxidative stress induces p53-dependent apoptosis in hepatoblastoma cell through its nuclear translocation.

Yamamoto H, Ozaki T, Nakanishi M, Kikuchi H, Yoshida K, Horie H, Kuwano H, Nakagawara A.

Genes Cells. 2007 Apr;12(4):461-71.

7.

The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.

Argentini M, Barboule N, Wasylyk B.

Oncogene. 2001 Mar 15;20(11):1267-75.

9.

Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis.

Pei XH, Bai F, Li Z, Smith MD, Whitewolf G, Jin R, Xiong Y.

Cancer Res. 2011 Apr 15;71(8):2969-77. doi: 10.1158/0008-5472.CAN-10-4300.

11.

The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent apoptosis.

Huang J, Xu LG, Liu T, Zhai Z, Shu HB.

FEBS Lett. 2006 Feb 6;580(3):940-7.

12.

Expression of a mutant p193/CUL7 molecule confers resistance to MG132- and etoposide-induced apoptosis independent of p53 or Parc binding.

Dowell JD, Tsai SC, Dias-Santagata DC, Nakajima H, Wang Z, Zhu W, Field LJ.

Biochim Biophys Acta. 2007 Mar;1773(3):358-66.

13.

A novel p53-binding domain in CUL7.

Kasper JS, Arai T, DeCaprio JA.

Biochem Biophys Res Commun. 2006 Sep 15;348(1):132-8.

PMID:
16875676
14.

p53-Associated Parkin-like cytoplasmic protein (Parc) short-interfering RNA (siRNA) alters p53 location and biology of Peyronie's disease fibroblasts.

Mulhall JP, Barnas J, Kobylarz K, Mueller A.

BJU Int. 2010 Dec;106(11):1706-13. doi: 10.1111/j.1464-410X.2010.09754.x.

16.

The ubiquitin ligase COP1 is a critical negative regulator of p53.

Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM.

Nature. 2004 May 6;429(6987):86-92.

PMID:
15103385
17.

Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage.

Cai X, Liu X.

Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):16958-63. doi: 10.1073/pnas.0804608105.

18.

MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells.

Rodriguez-Lopez AM, Xenaki D, Eden TO, Hickman JA, Chresta CM.

Mol Pharmacol. 2001 Jan;59(1):135-43.

19.

The importance of p53 location: nuclear or cytoplasmic zip code?

O'Brate A, Giannakakou P.

Drug Resist Updat. 2003 Dec;6(6):313-22. Review.

PMID:
14744495
20.

Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358.

Saitoh H, Pizzi MD, Wang J.

J Biol Chem. 2002 Feb 15;277(7):4755-63.

Supplemental Content

Support Center